RecruitingNot ApplicableNCT07534735

Growth and Health Efficacy of Novel Infant Formula : A Randomized Trial

Growth, Gut Health, Immune Function, and Sleep Status in Infants and Young Children Fed With Novel Infant Formula : A Randomized Trial


Sponsor

Biostime (Changsha) Nutrition Foods Limited

Enrollment

120 participants

Start Date

May 27, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Randomized, controlled study consisting of three parallel arms to investigate the effects of novel infant formula on growth, gut health, immune function, and sleep status in healthy infants and young children aged 12-18 months.


Eligibility

Min Age: 12 MonthsMax Age: 18 Months

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Investigational Formula 1 and Investigational Formula 2 for people with infant growth. The study is currently recruiting participants at 1 location. People eligible for this study include aged 12 Months to 18 Months.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTInvestigational Formula 1

The infant formula is provided in powdered form that provides the appropriate amount of protein, carbohydrates, fats, vitamins, and minerals

DIETARY_SUPPLEMENTInvestigational Formula 2

The infant formula is provided in powdered form that provides the appropriate amount of protein, carbohydrates, fats, vitamins, and minerals


Locations(1)

Shenzhen University

Shenzhen, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07534735


Related Trials